Abstract

Diabetic nephropathy is one of most frequent complications of diabetes, and is the major cause of end-stage disease in diabetic patients. The present study investigated the roles and mechanisms of Rhein-8-O-β-D-glucopyranoside (Rg) protecting human mesangial cells (HMCs) from high glucose (HG)-induced apoptosis. Using a Cell Counting Kit-8 assay the proliferation of HMCs was analyzed, and flow cytometry was applied to detect apoptosis. The apoptosis-associated protein Bcl-2, caspase-3 and members of the transforming growth factor-β1 (TGF-β1)/Smad signaling pathway were analyzed using a western blotting assay. HG significantly induced HMC apoptosis, and Rg markedly attenuated the HG-induced apoptosis. HG decreased the Bcl-2 expression and increased the caspase-3 expression, and Rg treatment recovered the expressions of Bcl-2 and caspase-3 affected by HG. The underlying mechanisms were further analyzed, and it was demonstrated that HG significantly upregulated the long intervening non-coding RNA (lincRNA) ANRIL expression level, downregulated let-7a expression and activated the TGF-β1/Smad signaling pathway; Rg treatment recovered the expressions of lincRNA ANRIL and let-7a, and inhibited the TGF-β1/Smad signaling pathway in the condition of HG. In conclusion, the present results suggested that Rg attenuated HG-induced apoptosis of HMCs by regulating the lincRNA ANRIL/let-7a/TGF-β1/Smad signaling pathway.

Highlights

  • Diabetic nephropathy (DN) is one of most frequent complications of diabetes, and is the major cause of end‐stage disease in diabetic patients [1]

  • The results showed that high glucose (HG) significantly induced the apoptosis of Human mesangial cells (HMCs), and 20 and 80 μM Rg could both inhibit the apoptosis induced by HG (Fig. 1A and B)

  • The present study hypothesized that Rg inhibited HG‐induced apoptosis of HMCs by inactivating the transforming growth factor‐β1 (TGF‐β1)/Smad signaling pathway

Read more

Summary

Introduction

Diabetic nephropathy (DN) is one of most frequent complications of diabetes, and is the major cause of end‐stage disease in diabetic patients [1]. DN is characterized by mesangial expansion, glomerular extracellular matrix (ECM) accumulation and renal interstitial fibrosis, and these pathological changes lead to chronic renal dysfunction [2]. Human mesangial cells (HMCs) which produce mesangial ECM constituents are located in the interpapillary space of the glomerular tufts [3]. Ye et al [4] reported that Norcantharidin could inhibit HMC proliferation and induce apoptosis in a dose and time‐dependent manner. Zhou et al [5] observed that mevalonate could stimulate HMC proliferation, increase the expression of Bcl‐2 and downregulate the expression of Bax in the HMCs. The present study demonstrated that Rhein‐8‐O‐β‐D‐glucopyranoside (Rg) could significantly inhibit high glucose (HG)‐induced HMC apoptosis; the underlying mechanisms were largely unknown

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call